Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-061643

Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WHITFIELD ROY A Director 2019-12-18 Option exercise +10,000 $9.24 $92,400 198,250 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
WHITFIELD ROY A Director 2019-12-18 Option exercise · Stock Option −10,000 30,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…